Goldenwell Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Goldenwell Biotech has a total shareholder equity of $84.7K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $228.1K and $143.3K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$53.23k |
Equity | US$84.72k |
Total liabilities | US$143.33k |
Total assets | US$228.06k |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GWLL's short term assets ($228.1K) exceed its short term liabilities ($1.4K).
Long Term Liabilities: GWLL's short term assets ($228.1K) exceed its long term liabilities ($141.9K).
Debt to Equity History and Analysis
Debt Level: GWLL is debt free.
Reducing Debt: GWLL has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GWLL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: GWLL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 59.6% each year